Loading...
Please wait, while we are loading the content...
Similar Documents
Triple-negative and basal-like breast cancer: implications for oncologists.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Lachapelle, Jacques Foulkes, William D. |
| Copyright Year | 2011 |
| Abstract | s?&vmview=abst_detail_view&conf ID=65& abstractID=35150; cited June 15, 2011] 14. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvantID=35150; cited June 15, 2011] 14. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008;26:1275–81. 15. Nahleh Z. Neoadjuvant chemotherapy for “triple negative” breast cancer: a review of current practice and future outlook. Med Oncol 2010;27:531–9. LACHAPELLE and FOULKES 164 Current OnCOlOgy—VOlume 18, number 4 Copyright © 2011 Multimed Inc. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC). 16. Ellis P, Barrett–Lee P, Johnson L, et al. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (tact): an open-label, phase iii, randomised controlled trial. Lancet 2009;373:1681–92. 17. Silver DP, Richardson AL, Eklund AC, et al. Efficacy of neoadjuvant cisplatin in triple-negative breast cancer. J Clin Oncol 2010;28:1145–53. 18. Byrski T, Gronwald J, Huzarski T, et al. Pathologic complete response rates in young women with brca1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol 2010;28:375–9. 19. Roché H, Conte P, Perez EA, et al. Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase iii studies. Breast Cancer Res Treat |
| Starting Page | 152 |
| Ending Page | 158 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.current-oncology.com/index.php/oncology/article/viewFile/824/693 |
| PubMed reference number | 21874112v1 |
| Volume Number | 18 |
| Issue Number | 4 |
| Journal | Current oncology |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Anthracyclines Basal-Like Breast Carcinoma CNS disorder Carcinoma breast stage IV Chemotherapy, Adjuvant Cisplatin Copyright Ethacrynic Acid Malignant neoplasm of breast Mammary Neoplasms Neoadjuvant Therapy Paramyotonia Congenita (disorder) Patients Pharmaceutical Adjuvants Pooled Sample Russell-Silver syndrome Silver Stevens-Johnson Syndrome Taxanes Triple Negative Breast Neoplasms capecitabine docetaxel ixabepilone performance status |
| Content Type | Text |
| Resource Type | Article |
